Risk factor
Negligible price volatility
Profitability factor
Strong margins and returns
About
Dallah Healthcare Company provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical policlinics, compounds, and lands; and the provision of manpower and support services to hospitals and medical centers. It also manufactures and distributes pharmaceutical, herbal, and cosmetic products to retail pharmacies, health and beauty stores, hospitals, and governmental agencies. In addition, the company engages in the management and operation of hospitals owned by third parties; and the provision of other support services. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was founded in 1994 and is based in Riyadh, Saudi Arabia. Dallah Healthcare Company is the subsidiary of Dallah Al-Barakah Holding.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/
Target Price
The average target price of 4004.SR is 141 and suggests 16% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell